GSK secures FDA approval for first RSV vaccine Arexvy in older adults
The approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 May 23
The approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy…
02 May 23
The US FDA accepted BMS’ supplemental Biologics License Application (sBLA) and granted Priority Review for Reblozyl, while the…
02 May 23
The final approval, which was sought by Avadel Pharmaceuticals in March this year, was granted based on the…
01 May 23
The subcutaneous, long-acting formulation of risperidone uses MedinCell’s SteadyTeq technology for ensuring a steady release of risperidone
28 Apr 23
The PREVNAR 20 vaccine has been developed based on more than 20 years of Pfizer’s research in developing…
27 Apr 23
Vowst (faecal microbiota spores, live-brpk), previously known as SER-109, is an orally administered microbiota-based therapeutic, indicated for the…
26 Apr 23
The accelerated approval has been given by the FDA based on a reduction in plasma NfL shown in…
12 Apr 23
HyQvia is a liquid medicine that contains Recombinant Human Hyaluronidase and immunoglobulins (Ig) from human plasma, infused under…
07 Apr 23
Janssen Pharmaceutical revealed that the FDA advised that the primary outcomes from the two phase 3 confirmatory studies…
05 Apr 23
Arbutus and Genevant accuse Pfizer and BioNTech of using their patented lipid nanoparticle (LNP) delivery technologies without a…